Martin McGlynn

2011

In 2011, Martin McGlynn earned a total compensation of $955.5K as President and CEO at StemCells, a 55% decrease compared to previous year.

Compensation breakdown

Bonus$187,688
Salary$525,000
Stock Awards$194,000
Other$48,819
Total$955,507

McGlynn received $525K in salary, accounting for 55% of the total pay in 2011.

McGlynn also received $187.7K in bonus, $194K in stock awards and $48.8K in other compensation.

Rankings

In 2011, Martin McGlynn's compensation ranked 5,810th out of 10,747 executives tracked by ExecPay. In other words, McGlynn earned more than 45.9% of executives.

ClassificationRankingPercentile
All
5,810
out of 10,747
46th
Division
Manufacturing
2,099
out of 3,960
47th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
305
out of 647
53rd
Industry group
Surgical, Medical, And Dental Instruments And Supplies
154
out of 361
57th
Industry
Surgical and Medical Instruments and Apparatus
82
out of 221
63rd
Source: SEC filing on October 31, 2013.

McGlynn's colleagues

We found four more compensation records of executives who worked with Martin McGlynn at StemCells in 2011.

2011

Rodney Young

StemCells

Chief Financial Officer

2011

Ann Tsukamoto

StemCells

EVP, Scientific and Strategic Alliances

2011

Ken Stratton

StemCells

General Counsel

2011

Stewart Craig

StemCells

EVP, Development and Operations

You may also like